Crossmark

Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment

Crossref DOI link: https://doi.org/10.1007/s00520-016-3329-5

Published Online: 2016-07-28

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zanville, Noah R.

Nudelman, Kelly N. H.

Smith, Dori J.

Von Ah, Diane

McDonald, Brenna C.

Champion, Victoria L.

Saykin, Andrew J.
Funding

Funding for this research was provided by:

National Cancer Institute (R01 CA101318)

National Cancer Institute (R01 CA087845)

National Cancer Institute (R25 CA117865))

National Cancer Institute (P30 CA082709)

Indiana Clinical and Translational Sciences Institute (UL1 RR025761)

Indiana Clinical and Translational Sciences Institute (C06RR020128)

Indiana Clinical and Translational Sciences Institute (S10RR027710)

National Institute on Aging (R01 AG019771)

National Institute on Aging (P30 AG010133)
License Information

Text and Data Mining valid from 2016-07-28

Version of Record valid from 2016-07-28
More Information

Article History

Received: 4 February 2016

Accepted: 3 July 2016

First Online: 28 July 2016

Compliance with ethical standards

:

: The authors have no conflicts of interest to disclose. The authors verify that they have full control of all primary data and agree, if requested, to allow the journal to verify the data from which all analyses were derived.

Document is current

Any future updates will be listed below